Next Science (ASX:NXS) Price-to-Tangible-Book : 5.00 (As of Jun. 07, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Price-to-Tangible-Book?

As of today (2024-06-07), Next Science's share price is A$0.265. Next Science's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.05. Hence, Next Science's Price to Tangible Book Ratio of today is 5.00.

The historical rank and industry rank for Next Science's Price-to-Tangible-Book or its related term are showing as below:

ASX:NXS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.91 Med: 13.53 Max: 21.47
Current: 5.3

During the past 6 years, Next Science's highest Price to Tangible Book Ratio was 21.47. The lowest was 4.91. And the median was 13.53.

ASX:NXS's Price-to-Tangible-Book is ranked worse than
80.54% of 858 companies
in the Drug Manufacturers industry
Industry Median: 2.255 vs ASX:NXS: 5.30

A closely related ratio is called PB Ratio. As of today, Next Science's share price is A$0.265. Next Science's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.07. Hence, Next Science's P/B Ratio of today is 4.02.

Next Science Price-to-Tangible-Book Historical Data

The historical data trend for Next Science's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Price-to-Tangible-Book Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

13.53

11.06

21.47

17.56

6.42

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial					21.47	9.23	17.56	-	6.42

Competitive Comparison of Next Science's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Next Science's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Next Science's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Next Science's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Next Science's Price-to-Tangible-Book falls into.

Next Science Price-to-Tangible-Book Calculation

Next Science's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.265	/	0.053
	=	5.00

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Next Science Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Next Science's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science (ASX:NXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

NXSCF:USA

Address

821 Pacific Highway, Suite 1902, Level 19, Tower A, The Zenith Building, Chatswood, NSW, AUS, 2067

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.

Next Science (ASX:NXS) Headlines

No Headlines